Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2024-06-03 AGM Information
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) dated June 3, 2024, regarding the publication of newspaper advertisements about the company's 30th Annual General Meeting (AGM) scheduled for June 29, 2024. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 30 and 47, which pertain to disclosures and announcements. The content is about notifying the exchanges of the advertisement publication for the AGM, not the AGM materials themselves or the AGM results. The document is relatively short and serves as an announcement or intimation rather than a detailed report or presentation. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or AGM Information (AGM-R). However, since it is about the advertisement/intimation of the AGM and not the AGM materials or voting results, the most appropriate classification is AGM Information (AGM-R). Confidence is high given the clear references to the AGM advertisement and regulatory citations.
2024-06-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated May 30, 2024, addressed to stock exchanges, informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is about announcing the schedule of investor meetings, not the meetings' transcripts or detailed presentations. The document is only 1435 characters long, which is quite brief and does not contain any financial data, analysis, or detailed report content. It is an announcement of a schedule rather than a report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings, but since it is only a schedule notice and not the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about upcoming investor meetings without substantive financial or presentation content.
2024-05-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content lists dates, venues, and types of meetings but does not contain any financial data, report content, or detailed presentations. It is an announcement of planned investor meetings rather than the meetings' content or transcripts. Therefore, it fits best under the category of Investor Presentation announcements or scheduling notices. However, since it is only an intimation of the schedule and not the presentation itself, the closest fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2024-05-27 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Corporate Presentation Q4 & FY24' and is addressed to stock exchanges pursuant to SEBI regulations, indicating it is a formal disclosure. The content includes detailed company overview, financial and operating highlights, strategy for future growth, and investment highlights. It is explicitly described as a presentation intended for analysts and investors. The document contains forward-looking statements and disclaimers typical of investor presentations. It does not contain full financial statements or detailed management discussion and analysis that would characterize an interim or annual report. The length (15,000 characters) and detailed content support it being a presentation rather than a brief announcement or a regulatory filing. Therefore, the document fits the category of an Investor Presentation (IP).
2024-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is about announcing dates and venues for investor meetings, with no financial data, report content, or detailed analysis included. The document is short (1776 characters) and serves as an announcement rather than a report or transcript. It does not fit categories like Annual Report, Earnings Release, or Call Transcript. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings without substantive financial or management content.
2024-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q4 and full fiscal year 2024 earnings conference call for Dr. Lal PathLabs. It includes management speeches, financial performance highlights, strategic initiatives, and a Q&A session with analysts. The presence of management speakers, detailed financial data for the quarter and full year, and the interactive Q&A format are characteristic of an earnings call transcript. The document explicitly states it is a transcript of the earnings conference call, confirming the classification. It is not a brief earnings release, annual report, or any other filing type. Therefore, the correct classification is Call Transcript (CT).
2024-05-15 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.